ISRG vs MSFT: Which Is the Better Buy?

Side-by-side comparison of Intuitive Surgical, Inc. and Microsoft Corporation β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-07-16.
Intuitive Surgical, Inc. Β· Healthcare
$388.97
+45.0% upside to fair value
Grade B High Quality
VS
Microsoft Corporation Β· Technology
$379.40
+45.0% upside to fair value
Grade A High Quality
QuantHub Verdict
MSFT trades at a lower forward P/E (22.5x). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric ISRG MSFT
Current Price $388.97 $379.40
Fair Value Estimate $564.01 $550.13
Upside to Fair Value +45.0% +45.0%
Market Cap $137.8B $2,818.3B
Forward P/E 46.5x 22.5x
EV / EBITDA 31.4x 14.2x
Price / Sales 13.0x 8.9x
Price / FCF 48.6x 38.6x
Revenue Growth YoY +23.0% +18.3%
Gross Margin 66.3% 68.3%
Operating Margin 30.5% 46.8%
Return on Equity 17.0% 33.1%
Dividend Yield 0% 0%
FCF Yield 2.06% 2.59%
Analyst Consensus Strong Buy Strong Buy
Investment Thesis
ISRG β€” Intuitive Surgical, Inc.
Intuitive Surgical, Inc. operates in the healthcare sector, specializing in medical devices with a strong focus on robotic-assisted surgery systems. The company demonstrates high business quality with a durable competitive moat supported by a 17.0% return on equity, robust gross margin of 66.3%, and solid operating margin of 30.5%. Revenue and earnings growth in the most recent quarter were impre…
MSFT β€” Microsoft Corporation
Microsoft Corporation is a leading global technology company specializing in cloud computing, productivity software, and enterprise platforms. The company benefits from a very strong and widening competitive moat supported by scale, switching costs, an integrated ecosystem, and disciplined capital allocation including large buybacks and dividends. Its business quality is high, demonstrated by a 3…
Accumulation Zones
Metric ISRG MSFT
Zone Low $423.01 $412.60
Zone High $479.41 $467.61
In Buy Zone? Yes Yes
← ISRG Research    MSFT Research β†’    All Research